Biotech
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 09/29/11 -- September 29, 2011 - Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the Company") announced today it and its wholly owned subsidiary, Cea ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 09/29/11 -- Theratechnologies Inc. (TSX: TH)(NASDAQ: THER) (Theratechnologies) announced today that it will issue its financial results for the third quarter of 2 ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 09/29/11 -- (OTCBB: BISU)(PINK SHEETS: BISU) - Bio Solutions Corp. is pleased to announce the closing of the acquisition of Type2 Defense: A powder form diabetic ...
WASHINGTON, DC: First and Only Partnering Event Focused Exclusively on Facilitating Access to Capital and Business Development in the Regenerative Medicine Field ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwire) -- 09/29/11 -- PharmaGap Inc. (TSX VENTURE: GAP) (OTCBB: PHRGF) ("PharmaGap" or "the Company") is pleased to announce the first of two provisional ...
JERSEY CITY, NJ: JERSEY CITY, NJ -- (Marketwire) -- 09/28/11 -- Aoxing Pharmaceutical (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 09/28/11 -- The international Structural Genomics Consortium (SGC) today announced $48.9 million in new funding has been attained. This renewed investment will all ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 09/28/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT), announced today that its President & Chief Executive Officer, Dr. Wayne Danter, provi ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/28/11 -- (TSX: NPC) announced today that it has been granted an important United States patent covering the composition of matter for the D-isomer o ...
ROCHESTER, MI: ROCHESTER, MI -- (Marketwire) -- 09/28/11 -- OPTIMIZERx Corporation (OTCBB: OPRX) today announced Zack's Investment Research coverage of the company. The following summarizes the Outlook and en ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/28/11 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") is pleased to report that efficacy studies conducted on end-user ...
CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwire) -- 09/27/11 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS) ("SCT" or the "Company") has posted an investor update on its corporate website - ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 09/27/11 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmac ...
SOUTH SAN FRANCISCO, CA: Findings Demonstrate the Potential Therapeutic Application of Inhibitors of Smooth Muscle Myosin for the Treatment of Hypertension ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 09/27/11 -- ProMetic BioSciences Inc. (TSX: PLI)- Accepted for 4 presentations at the American Society of Nephrology ("ASN") forthcoming Annual Meeting- Ne ...
OREM, UT: OREM, UT -- (Marketwire) -- 09/27/11 -- Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries, annou ...
MONTREAL, CANADA: - Regulator has cease-traded Afexa Rights Plans - Choice of $0.81 in cash or 0.0217 of a Paladin share per Afexa share - Offer remains for any and all Afexa shares - Minimal and customary conditions ...
VANCOUVER, CANADA: VANCOUVER, CANADA -- (Marketwire) -- 09/26/11 -- The Centre for Drug Research and Development's (CDRD's) commercial arm, CDRD Ventures Inc. (CVI), is pleased to announce they have entered ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 09/26/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces th ...
